JPS5241212A - Instant solution of acetyl salicylic acid for injection - Google Patents
Instant solution of acetyl salicylic acid for injectionInfo
- Publication number
- JPS5241212A JPS5241212A JP51095886A JP9588676A JPS5241212A JP S5241212 A JPS5241212 A JP S5241212A JP 51095886 A JP51095886 A JP 51095886A JP 9588676 A JP9588676 A JP 9588676A JP S5241212 A JPS5241212 A JP S5241212A
- Authority
- JP
- Japan
- Prior art keywords
- injection
- salicylic acid
- acetyl salicylic
- instant solution
- instant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 title 1
- 229960001138 acetylsalicylic acid Drugs 0.000 title 1
- 238000002347 injection Methods 0.000 title 1
- 239000007924 injection Substances 0.000 title 1
- 239000000243 solution Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
- A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7524981A FR2320759A1 (fr) | 1975-08-11 | 1975-08-11 | Solution d'acide acetylsalicylique extemporanee injectable |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS5241212A true JPS5241212A (en) | 1977-03-30 |
Family
ID=9158984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51095886A Pending JPS5241212A (en) | 1975-08-11 | 1976-08-11 | Instant solution of acetyl salicylic acid for injection |
Country Status (10)
| Country | Link |
|---|---|
| JP (1) | JPS5241212A (enExample) |
| AU (1) | AU1673776A (enExample) |
| BE (1) | BE845038A (enExample) |
| DE (1) | DE2635843A1 (enExample) |
| ES (1) | ES450583A1 (enExample) |
| FR (1) | FR2320759A1 (enExample) |
| GB (1) | GB1525765A (enExample) |
| NL (1) | NL7608951A (enExample) |
| SE (1) | SE7608909L (enExample) |
| ZA (1) | ZA764781B (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1984001501A1 (fr) * | 1978-07-04 | 1984-04-26 | Kazuhiro Tsukada | Composition de dopa fortement concentree et son procede de preparation |
| CN102531969A (zh) * | 2011-12-28 | 2012-07-04 | 蚌埠丰原医药科技发展有限公司 | 一种无菌l-精氨酸的制备方法 |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2495608A1 (fr) * | 1980-12-04 | 1982-06-11 | Morelle Jean | Nouveaux derives de l'acide aspartique et leurs usages |
| GB8929076D0 (en) * | 1989-12-22 | 1990-02-28 | Scras | Treatment of shock by blocking agents of edrf effect or formation |
| GB9200114D0 (en) * | 1992-01-04 | 1992-02-26 | Scras | Dual inhibitors of no synthase and cyclooxygenase |
| ES2323286T3 (es) * | 2005-06-29 | 2009-07-10 | Verisfield (Uk) Ltd. | Composiciones farmaceuticas de risperidona en disolucion acuosa. |
| CN101380329B (zh) * | 2008-10-29 | 2010-11-17 | 海南本创医药科技有限公司 | 一种精氨酸阿司匹林及其粉针剂的制备方法 |
| EP2429494B1 (en) * | 2009-05-11 | 2013-07-17 | King Saud University | Preparation of acetyl salicylic acid/glutamic acid complex for oral administration |
| CN117982446A (zh) | 2016-06-28 | 2024-05-07 | 阿萨德股份有限公司 | 双组分组合物 |
| EP3501523A1 (en) | 2017-12-22 | 2019-06-26 | Asamedic AS | Two-component compositions comprising acetyl salicylic acid and a carbonate salt |
| EP3501522A1 (en) | 2017-12-22 | 2019-06-26 | Asamedic AS | Compositions comprising acetylsalicylic acid and a phosphate salt |
| WO2023198294A1 (en) * | 2022-04-14 | 2023-10-19 | Hyloris Developments Sa | Acetyl salicylic acid composition for intravenous administration, its storage, production and use |
-
1975
- 1975-08-11 FR FR7524981A patent/FR2320759A1/fr active Granted
-
1976
- 1976-08-09 ES ES450583A patent/ES450583A1/es not_active Expired
- 1976-08-09 ZA ZA764781A patent/ZA764781B/xx unknown
- 1976-08-10 SE SE7608909A patent/SE7608909L/xx unknown
- 1976-08-10 BE BE2055232A patent/BE845038A/xx unknown
- 1976-08-10 DE DE19762635843 patent/DE2635843A1/de active Pending
- 1976-08-11 JP JP51095886A patent/JPS5241212A/ja active Pending
- 1976-08-11 GB GB33481/76A patent/GB1525765A/en not_active Expired
- 1976-08-11 AU AU16737/76A patent/AU1673776A/en not_active Expired
- 1976-08-11 NL NL7608951A patent/NL7608951A/xx not_active Application Discontinuation
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1984001501A1 (fr) * | 1978-07-04 | 1984-04-26 | Kazuhiro Tsukada | Composition de dopa fortement concentree et son procede de preparation |
| CN102531969A (zh) * | 2011-12-28 | 2012-07-04 | 蚌埠丰原医药科技发展有限公司 | 一种无菌l-精氨酸的制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| DE2635843A1 (de) | 1977-02-24 |
| ES450583A1 (es) | 1978-02-01 |
| ZA764781B (en) | 1977-07-27 |
| NL7608951A (nl) | 1977-02-15 |
| FR2320759B1 (enExample) | 1979-09-14 |
| GB1525765A (en) | 1978-09-20 |
| BE845038A (fr) | 1976-12-01 |
| FR2320759A1 (fr) | 1977-03-11 |
| SE7608909L (sv) | 1977-02-12 |
| AU1673776A (en) | 1978-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS5219628A (en) | 11hydroxyy33aminoalkanee1* 11diphosphonic acid | |
| JPS51125320A (en) | Olefine derivatives of amino acid | |
| ZA762285B (en) | New phenyl-alkane-carboxylic acid derivatives | |
| MY8100161A (en) | Hydroxybenzylmalonic acid derivatives | |
| JPS521010A (en) | Preparation of hemoglobin solution without substrate | |
| JPS5241212A (en) | Instant solution of acetyl salicylic acid for injection | |
| JPS51133245A (en) | Nnarylanthranyl acid | |
| JPS5212134A (en) | Compositions containing organicctitanic acid salts | |
| NZ180785A (en) | Preparation of 5-aroyl-1-lower alkylpyr-rolf-2-acetic acid derivatives | |
| ZA764952B (en) | Derivatives of phenoxyalkylacarboxylic acids | |
| GB1550166A (en) | Process for the preparation of anhydrous percarboxylic acid solutions in benzene | |
| JPS5234918A (en) | Production of gmmaglobulin suitable for dosing into vein | |
| ZA75194B (en) | New derivatives of phnylacetic acid | |
| ZA765438B (en) | Furanose-o-pyridylcarboxylic acid esters | |
| AU1685576A (en) | Vinylthionophosphoric acid esters | |
| AU1522876A (en) | D1-and 8r-9-fluoro-prostadianoic acid | |
| JPS52142008A (en) | Mixtures of poly branch monocarboxylic acid | |
| JPS5246041A (en) | Production of alkylsulphonic acid dhenylester | |
| AU2051676A (en) | 7-acylamido-3-cephem-4-carboxylic acid | |
| GB1533284A (en) | Process for the preparation of perpropionic acid solution | |
| GB1521784A (en) | Process for the preparation of percarboxylic acid solutions | |
| IE43457L (en) | 1-deoxyribofuranuronic acid derivatives | |
| ZA764209B (en) | Azanaphthaleneacetic acid derivatives | |
| ZA7602527D (en) | Process for the preparation of perpropionic acid solution | |
| AU1271276A (en) | Acid esters |